Coloplast A/S (CBHD) Financial Statements
Coloplast A/S Financial Overview
Coloplast A/S's market cap is currently $14.52B. The company's EPS TTM is $12.26; its P/E ratio is 39.34; and it has a dividend yield of 4.75%. Coloplast A/S is estimated to report earnings on November 3, 2026, and the estimated EPS forecast is $0.79. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 27.87B | $ 27.03B | $ 24.50B | $ 22.58B | $ 19.43B |
| Gross Profit | $ 18.14B | $ 18.27B | $ 16.33B | $ 15.53B | $ 13.31B |
| Operating Income | $ 7.58B | $ 7.32B | $ 6.77B | $ 6.44B | $ 6.36B |
| EBITDA | $ 8.34B | $ 8.57B | $ 7.73B | $ 7.23B | $ 7.08B |
| Net Income | $ 3.64B | $ 5.05B | $ 4.78B | $ 4.71B | $ 4.83B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 947.00M | $ 788.00M | $ 911.00M | $ 633.00M | $ 674.00M |
| Total Assets | $ 48.37B | $ 48.07B | $ 48.16B | $ 34.96B | $ 15.84B |
| Total Debt | $ 22.64B | $ 22.63B | $ 19.57B | $ 18.71B | $ 2.79B |
| Net Debt | $ 21.69B | $ 21.84B | $ 18.66B | $ 18.29B | $ 2.34B |
| Total Liabilities | $ 32.24B | $ 30.13B | $ 30.86B | $ 26.66B | $ 7.67B |
| Stockholders' Equity | $ 16.12B | $ 17.94B | $ 17.30B | $ 8.29B | $ 8.17B |
| Cash Flow | |||||
| Free Cash Flow | $ 5.34B | $ 1.60B | $ 2.98B | $ 3.96B | $ 3.32B |
| Operating Cash Flow | $ 6.64B | $ 2.77B | $ 4.23B | $ 5.10B | $ 5.29B |
| Investing Cash Flow | $ -1.25B | $ -1.34B | $ -8.96B | $ -11.76B | $ -2.01B |
| Financing Cash Flow | $ -5.19B | $ -1.52B | $ 5.26B | $ 6.59B | $ -3.18B |
Currency in DKK
